Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (отвара нови прозор)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Извор‎: Anesth Analg 2006;102(3):731-7.

Индекс‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (отвара нови прозор)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (отвара нови прозор)

Basta MN, Stricker PA, Taylor JA.

Извор‎: Pediatr Surg Int 2012;28(11):1059-69.

Индекс‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (отвара нови прозор)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (отвара нови прозор)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Извор‎: Br J Anaesth 2012;108(5):830-7.

Индекс‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (отвара нови прозор)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (отвара нови прозор)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Извор‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Индекс‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (отвара нови прозор)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (отвара нови прозор)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Извор‎: Ann Thorac Surg 2000;70(4):1308-12.

Индекс‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (отвара нови прозор)

The Bayer 022 compassionate-use pediatric study. (отвара нови прозор)

Coniff RF.

Извор‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Индекс‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (отвара нови прозор)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (отвара нови прозор)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Извор‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Индекс‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (отвара нови прозор)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (отвара нови прозор)

Guay J, de Moerloose P, Lasne D.

Извор‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Индекс‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (отвара нови прозор)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (отвара нови прозор)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Извор‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Индекс‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (отвара нови прозор)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (отвара нови прозор)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Извор‎: PLoS One 2015;10(5):e0126514.

Индекс‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (отвара нови прозор)

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (отвара нови прозор)

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Извор‎: Int J Clin Exp Pathol 2015;8(7):7978-87.

Индекс‎: PubMed 26339364

https://www.ncbi.nlm.nih.gov/pubmed/26339364 (отвара нови прозор)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (отвара нови прозор)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Извор‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Индекс‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (отвара нови прозор)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (отвара нови прозор)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Извор‎: Br J Anaesth 2013;110(4):615-21.

Индекс‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (отвара нови прозор)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (отвара нови прозор)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Извор‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Индекс‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (отвара нови прозор)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (отвара нови прозор)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Извор‎: Ann Card Anaesth 2015;18(1):23-6.

Индекс‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (отвара нови прозор)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (отвара нови прозор)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Извор‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Индекс‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (отвара нови прозор)

The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (отвара нови прозор)

Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.

Извор‎: Anesth Analg 1997;84(5):990-6.

Индекс‎: PubMed 9141920

https://www.ncbi.nlm.nih.gov/pubmed/9141920 (отвара нови прозор)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (отвара нови прозор)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Извор‎: Eur J Anaesthesiol 2015;32(12):844-50.

Индекс‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (отвара нови прозор)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (отвара нови прозор)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Извор‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Индекс‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (отвара нови прозор)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (отвара нови прозор)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Извор‎: Ann Card Anaesth 2010;13(2):110-5.

Индекс‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (отвара нови прозор)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (отвара нови прозор)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Извор‎: Anesthesiology 2015;122(4):746-58.

Индекс‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (отвара нови прозор)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (отвара нови прозор)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Извор‎: Ann Thorac Surg 2011;92(3):958-63.

Индекс‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (отвара нови прозор)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (отвара нови прозор)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Извор‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Индекс‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (отвара нови прозор)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (отвара нови прозор)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Извор‎: Ann Thorac Surg 2007;84(1):161-8.

Индекс‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (отвара нови прозор)

Pediatric off-label use of recombinant factor VIIa. (отвара нови прозор)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Извор‎: Pediatrics 2009;123(3):1066-72.

Индекс‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (отвара нови прозор)

Factor VII for excessive bleeding following congenital heart disease surgery. (отвара нови прозор)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Извор‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Индекс‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (отвара нови прозор)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (отвара нови прозор)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Извор‎: Paediatr Anaesth 2009;19(4):364-70.

Индекс‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (отвара нови прозор)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (отвара нови прозор)

Guzzetta NA, Russell IA, Williams GD.

Извор‎: Anesth Analg 2012;115(2):364-78.

Индекс‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (отвара нови прозор)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (отвара нови прозор)

Okonta KE, Edwin F, Falase B.

Извор‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Индекс‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (отвара нови прозор)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (отвара нови прозор)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Извор‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Индекс‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (отвара нови прозор)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (отвара нови прозор)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Извор‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Индекс‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (отвара нови прозор)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (отвара нови прозор)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Извор‎: J Clin Anesth 2014;26(3):204-11.

Индекс‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (отвара нови прозор)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (отвара нови прозор)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Извор‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Индекс‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (отвара нови прозор)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (отвара нови прозор)

Tobias JD, Berkenbosch JW, Russo P.

Извор‎: Pediatr Crit Care Med 2003;4(1):49-51.

Индекс‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (отвара нови прозор)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (отвара нови прозор)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Извор‎: J Intensive Care Med 2004;19(5):270-3.

Индекс‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (отвара нови прозор)

Recombinant activated factor VII in cardiac surgery: a systematic review. (отвара нови прозор)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Извор‎: Ann Thorac Surg 2007;83(2):707-14.

Индекс‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (отвара нови прозор)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (отвара нови прозор)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Извор‎: Pediatr Crit Care Med 2009;10(5):572-82.

Индекс‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (отвара нови прозор)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (отвара нови прозор)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Извор‎: Pediatr Cardiol 2013;34(1):119-24.

Индекс‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (отвара нови прозор)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (отвара нови прозор)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Извор‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Индекс‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (отвара нови прозор)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (отвара нови прозор)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Извор‎: Artif Organs 2010;34(11):955-60.

Индекс‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (отвара нови прозор)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (отвара нови прозор)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Извор‎: Eur J Anaesthesiol 2014;31(6):317-26.

Индекс‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (отвара нови прозор)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (отвара нови прозор)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Извор‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Индекс‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (отвара нови прозор)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (отвара нови прозор)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Извор‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Индекс‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (отвара нови прозор)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (отвара нови прозор)

Noga T, Bruce AA, Blain H, Nahirniak S.

Извор‎: Vox Sang 2016;110(3):253-7.

Индекс‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (отвара нови прозор)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (отвара нови прозор)

Guay J, de Moerloose P, Lasne D.

Извор‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Индекс‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (отвара нови прозор)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (отвара нови прозор)

Macksey LF, White B.

Извор‎: AANA J 2007;75(4):261-4.

Индекс‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (отвара нови прозор)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (отвара нови прозор)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Извор‎: Ann Surg 2010;251(2):217-28.

Индекс‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (отвара нови прозор)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (отвара нови прозор)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Извор‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Индекс‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (отвара нови прозор)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (отвара нови прозор)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Извор‎: Ann Card Anaesth 2012;15(1):26-31.

Индекс‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (отвара нови прозор)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (отвара нови прозор)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Извор‎: Artif Organs 2010;34(11):955-60.

Индекс‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (отвара нови прозор)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (отвара нови прозор)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Извор‎: Br J Anaesth 2015;114(1):91-102.

Индекс‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (отвара нови прозор)